Professor Holst discusses his current research and the most important current findings in diabetes.
1. In today’s post-genomic era, are there any major endocrine hormones similar to GLP-1 left to discover? (0:12)
2. Will ‘diet pills’ will ever be able to outperform lifestyle modifications for weight loss? (1:01)
3. What will be the next big therapeutic breakthrough in diabetes and obesity research? (4:37)
4. With the current obesity epidemic, what is the long-term outlook for obesity-related diseases such as type 2 diabetes? (5:41)
5. What are your highlights of EASD 2018 so far? (7:27)
Speaker’s disclosures: Professor Holst has nothing to disclose in relation to this video interview.
Filmed at the European Association for the Study of Diabetes (EASD) annual meeting, Berlin, Germany, 2018
Share this Video
Related Videos In Diabetes
Andrew Boulton, IDF 2021 – Anticipated congress highlights
It was a pleasure to meet with IDF President, Prof. Andrew Boulton (University of Manchester, UK) ahead of this year’s virtual meeting to discuss anticipated congress highlights and the relationship between COVID-19 and diabetes. Questions What do you expect to be the highlights of this year’s IDF Congress? (0:20-1:30) What have we learned about the […]
Welcome to the IDF Virtual Congress 2021
Programme Chair Prof. João Filipe Raposo introduces the programme for the International Diabetes Federation (IDF) Virtual Congress 2021 (December 6-11) focusing on diabetes complications and the links between COVID-19 and diabetes. https://www.idf2021.org
Matthew Budoff, ENDO 2021: Findings from a Substudy of the VERTIS CV Trial – Ertugliflozin for T2DM & ASCVD
We caught up with Professor Matthew Budoff (UCLA and Lundquist Institute, Torrance, CA, US) to discuss ertugliflozin in patients with type 2 diabetes mellitus and established atherosclerotic cardiovascular disease inadequately controlled with metformin and sulfonylurea (Clinical Trial Identifier: NCT01986881). ‘Efficacy and Safety of Ertugliflozin in Patients With Type 2 Diabetes Mellitus and Established Cardiovascular Disease […]
Journal articles and more to your inbox
Get the latest clinical insights from touchENDOCRINOLOGYSign me up!